Homa Ir

2

Review clinical trials related to Homa Ir. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

The primary objective of this study is to assess the effect of enobosarm on total body weight

Participants needed: 200
Trial details
Phase: Phase 2Age: 65-100Biological sex: AllType: InterventionalSponsor: Veru Inc.Updated: Jul 1, 2026Locations: 14
Eligibility criteria

Provide informed consent from the subject or the subject's legally authorized re... [+7]

Known hypersensitivity or allergy to enobosarm or a GLP-1 receptor agonist [+27]

Status: Recruiting

The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational Study

The aim of this study is to evaluate the effect of metabolic markers (HOMA-IR, triglyceride/HDL ratio, HbA1c, waist and hip circumference measurements, BMI, etc.) on pain and central sensitization in patients diagnosed with lipedema. The primary objective is to investigate the association between metabolic markers and central sensitization. The secondary objective is to assess the relationship between metabolic markers and pain intensity, pain phenotype, and functional status.

Participants needed: 59
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Marmara UniversityUpdated: Mar 12, 2026Locations: 1
Eligibility criteria

Being female and aged 18 years or older [+3]

Presence of a history of malignancy, active infection, inflammatory rheumatic di... [+12]